Regeneron Pharmaceuticals Inc. buy Snowman
Start price
07.12.23
/
50%
€777.50
Target price
07.12.24
€900.00
Performance (%)
-4.51%
End price
08.12.24
€742.40
Summary
This prediction ended on 08.12.24 with a price of €742.40. With a performance of -4.51%, the BUY prediction for Regeneron Pharmaceuticals Inc. by Snowman closed slightly in the red. Snowman has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.250% | 0.250% | -0.741% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
Comments by Snowman for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Snowman gewählte maximale Laufzeit wurde überschritten